Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Changgui Li and Fengcai Zhu.
Changgui Li
Connection Strength
0.439
Fengcai Zhu
  1. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021 02; 21(2):181-192.
    View in: PubMed
    Score: 0.228
  2. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med. 2009 Dec 17; 361(25):2414-23.
    View in: PubMed
    Score: 0.106
  3. Immunogenicity and Safety of a Sabin Strain-Based Inactivated Polio Vaccine: A Phase 3 Clinical Trial. J Infect Dis. 2019 10 08; 220(10):1551-1557.
    View in: PubMed
    Score: 0.053
  4. Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women. Sci China Life Sci. 2020 Apr; 63(4):582-591.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.